Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

Daratumumab (DARA) is a human CD38-specific IgG1 antibody that is in clinical development for the treatment of multiple myeloma (MM). The potential for IgG1 antibodies to induce macrophage-mediated phagocytosis, in combination with the known presence of macrophages in the tumor microenvironment in M...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :MAbs
Главные авторы: Overdijk, Marije B, Verploegen, Sandra, Bögels, Marijn, van Egmond, Marjolein, van Bueren, Jeroen J Lammerts, Mutis, Tuna, Groen, Richard WJ, Breij, Esther, Martens, Anton CM, Bleeker, Wim K, Parren, Paul WHI
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis 2015
Предметы:
Reports
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4622648/
https://ncbi.nlm.nih.gov/pubmed/25760767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2015.1007813
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы